(Q40489254)

21 September 2017

title

Prospective audit of treatment of paediatric febrile neutropenia in Australasia (English)

1 reference

21 September 2017

3

Skeen J

1 reference

21 September 2017

Chamberlain JD

1

1 reference

21 September 2017

Smibert E

series ordinal

2

1 reference

21 September 2017

Alvaro F

series ordinal

4

1 reference

21 September 2017

publication date

1 November 2005

1 reference

Journal of Paediatrics and Child Health

21 September 2017

published in

1 reference

21 September 2017

volume

41

1 reference

21 September 2017

issue

11

1 reference

21 September 2017

page(s)

598-603

1 reference

A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Can

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Treatment of febrile neutropenia: what is new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Randomized placebo-controlled trial of oral antibiotics in pediatric oncology patients at low-risk with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Evolving concepts of management of febrile neutropenia in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2005.00729.X

10.1111/J.1440-1754.2005.00729.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference